BridgeBio publishes DISCOVER-ATTR digital registry presentation on ATTR-CM data integration

• BridgeBio published results from the DISCOVER-ATTR study, a fully decentralized, patient-led digital registry for ATTR-CM.
• Remote enrollment reached 20 participants. EHR portal connections succeeded for 17, or 85%.
• Average longitudinal EHR coverage was 10.6 years. Data captured 34 hospitalizations, 25 ED visits, 1,825 outpatient encounters.
• Wearable sharing reached 30% of participants, supporting analysis of physiologic trends around acute events.
• Registry approach aims to map ATTR-CM disease trajectories, with potential to scale to other rare cardiovascular diseases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.